Recruiting Asthma Studies in Mobile
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)
The objective of this clinical study is to investigate the safety, tolerability, and efficacy of dexpramipexole in participants with inadequately controlled severe eosinophilic asthma....
A Study to Investigate the Effect on Lung Function of BDA Formulated With a New Propellant (HFO) Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma
The purpose of this study is to assess the PD equivalence of the approved asthma combination therapy, BDA, delivered using the proposed replacement propellant HFO compared with BDA delivered using the...
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
The primary purpose of this study is to evaluate the effects of Fluticasone Furoate (FF)/ Umeclidinium (UMEC)/ Vilanterol (VI) on lung function compared with FF/VI after 24 weeks of treatment....
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition t...
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)
A study to evaluate the efficacy and safety of benralizumab administered subcutaneously in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of as...
A Study to Evaluate Solriktug in Adult Participants With Asthma
Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma....
About Asthma Clinical Trials in Mobile
Asthma is a chronic respiratory condition where the airways become inflamed and narrow, causing difficulty breathing, wheezing, and coughing. It affects over 300 million people worldwide. Treatment includes inhaled corticosteroids, bronchodilators, and biologics for severe asthma.
There are currently 6 asthma clinical trials recruiting participants in Mobile, AL. These studies are seeking a combined 2,196 participants. Research is being sponsored by Areteia Therapeutics, AstraZeneca, GlaxoSmithKline and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Asthma Clinical Trials in Mobile — FAQ
Are there asthma clinical trials in Mobile?
Yes, there are 6 asthma clinical trials currently recruiting in Mobile, AL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Mobile?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Mobile research site will contact you about next steps.
Are clinical trials in Mobile free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Mobile studies also compensate for your time and travel.
What asthma treatments are being tested?
The 6 active trials in Mobile are testing new therapies including novel drugs, biologics, and treatment approaches for asthma.
Data updated March 2, 2026 from ClinicalTrials.gov